LDR is now Zimmer Biomet

This survey is an FDA requirement for Class III, PMA Approved Devices and is required annually until 2023.

LDR is surveying all Mobi-C surgeons as a part of this commitment to the FDA.

The deadline for responses is June 24th, 2016.

Fields marked * are Required.

Step 1: Reporting Surgeon and Clinical Center Information

How many patients have you implanted with the Mobi-C during the past year? *

In the past year have any of the following been observed in the patients you have previously implanted with the Mobi-C: *

  • Heterotopic ossification, Device Malfunction, Device removal, Other Serious device-related complication

Please carefully review your responses for accuracy and completeness, then click the button below to continue to the next step.

For questions or concerns about this form please contact 512-344-3333.